Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection

European Journal of Clinical Nutrition

Volumn 51, Issue 4, 1997, Pages 266-272

  Look, M P ^a   Rockstroh, J K ^a   Rao, G S ^a   Kreuzer, K A ^a   Barton, S ^a   Lemoch, H ^a   Sudhop, T ^a   Hoch, J ^a   Stockinger, K ^b   Spengler, U ^a   Sauerbruch, T ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Privates Inst Immunol M   (Germany)

Author keywords

AIDS; Glutathione; Glutathione peroxidase; HIV infection; Plasma thiols; Serum selenium

Indexed keywords

ANTIOXIDANT; BETA 2 MICROGLOBULIN; ERYTHROCYTE ENZYME; GLUTATHIONE; GLUTATHIONE PEROXIDASE; NEOPTERIN; SELENIUM; THIOL; TUMOR NECROSIS FACTOR RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE CLASSIFICATION; DISEASE COURSE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HEPATITIS C VIRUS; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY;

EID: 0030893979     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600401     Document Type: Article

References (49)

1. + lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection. Blood 86(1), 258-267.
2. Barditch-Crovo P, Svobodov V & Lietman P (1995): Apparent deficiency of glutathionine in the PBMC's of people with AIDS depends on method of expression. J. Acquir. Immune. Defic. Syndr. Hum. Retrovir. 8, 313-314.
3. Beck K, Scramel P, Hedl A, Jaeger H & Kaboth W (1990): Serum trace element levels in HIV-infected subjects. Biol. Trace. Elem. Res. 259, 2850-2851.
4. Borum P, Goldberg D, Lederman M, Skowron G & Rowe W (1992): Altered glutathione status of HIV positive patients. FASEB J 6, 5.
5. Buhl R, Holroyd KJ, Mastrangeli A, Cantin AM, Jaffe HA, Wells FB, Saltini C & Crystal RG (1989): Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 2, 1294-1297.
6. Centers for Disease Control (1992): 1993 revised classification system for HIV-infection and expanded surveillance case definition among adolescents and adults. MMWR 41(RR-17), 1-19.
7. Christensen MJ & Pusey NW (1994): Binding of nuclear proteins to transcription regulatory elements in selenium deficiency. Biochem. Biophys. Acta. 1225, 338-341.
8. Cirelli A, Ciardi M, De Simone C, Sorice F, Giordano R, Ciaralli L & Constantini S (1991): Serum selenium concentration and disease progress with HIV-infection. Clin. Biochem. 24, 211-214.
9. Constans J, Pellegrin JL Claire S, Simonoff M, Pellegrin I, Fleury H, Leng B & Conri C (1995): Serum selenium predicts outcome in HIV infection. J. Acquir. Immune. Defic. Syndr. Hum. Retrovir. 10(3), 392.
10. Coodley GO, Nelson HD, Loveless MO & Folk C (1993): β-carotene in HIV infection. J. Acquir. Immune. Defic. Syndr. Hum. Retrovir. 6, 272-276.
11. Delmas-Beauvieux MC, Penchant E, Couchouron A, Constans J, Sergeant C, Simonoff M, Pellegrin JL, Leng B, Conri C & Clerc M (1996): The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or β-carotene. Am. J. Clin. Nutr. 64 101-107.
12. de Quay B, Malinverni R & Lauterburg BH (1992): Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS 6, 815-819.
13. Drge W (1993): Cysteine and glutathione deficiency in AIDS patients: A rationale for the treatment with N-acetylcysteine. Pharmacology 46, 61-65.
14. Dworkin BM, Rosenthal WS, Wormser GP, Weiss L, Nunez M, Joline C & Herp A (1988): Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and AIDS-related complex. Biol. Trace. Elem. Res 15, 167-177.
15. Dworkin BM (1994): Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem. Biol. Interact. 91 181-186.
16. Eck HP, Gmünder H, Hartmann M, Petzoldt D, Daniel V & Drge W (1980): Low concentration of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol. Chem. Hoppe. Seyler. 370 101-108.
17. Ehret A, Westendorp MO, Herr I, Debatin KM, Heeney JL, Frank R & Krammer PH (1996): Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis. J. Virol. 9, 6502-6507.
18. Fahey JL, Taylor JMG, Detels R, Hofman B, Melmed R, Nishanian P & Giorgi JV (1990): The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type I. N. Engl. J. Med. 322, 166-172.
19. Favier A, Sappey C, Leclerc P, Faure P & Micoud M (1994): Antioxidant status and lipid peroxidation in patients infected with HIV. Chem. Biol. Interact. 91(2-3), 165-180.
20. Flores SC, Marecki JC, Harper KP, Bose SK, Nelson SK & McCord JM (1993): Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc. Natl. Acad. Sci. USA 90, 7632-7636.
21. Godfried MH, van der Poll T, Jansen J, Romijin JA, Eeftinck Schattenkerk LKM, Endert E, van Deventer SJH & Sauerwein HP (1993): Soluble receptors for tumor necrosis factor: A putative marker of disease progression in HIV infection. AIDS 7, 33-36.
22. Godfried MH, van der Poll T, Weverling GJ, Mulder JW, Jansen J, van Deventer SJH & Sauerwein HP (1994): Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J. Inf. Dis. 169, 739-745.
23. Greenspan HC & Aruoma OI (1994): Oxidative stress and apoptosis in HIV infection: a role for plant derived metabolites with synergistic antioxidant activity. Immunol. Today 15(5), 209-213.
24. Halliwell B & Cross CE (1991): Reactive oxygen species, antioxidants and acquired immunodeficiency syndrome. Sense or speculation? Arch. Intern. Med. 151, 29-31.
25. Helbling V, von Overbeck J & Lauterburg BH (1996): Decreased release of glutathione into the systemic circulation of patients with HIV-infection. Eur. J. Clin. Invest. 26, 38-44.
26. Ho WZ & Douglas SD (1992): Glutathione and N-acetylcysteine suppression of human immunodeficiency virus replication in human monocyte/ macrophages in vitro. AIDS Res. Hum Retrovir. 8(7), 1249-1253.
27. Kiremdjian-Schumacher L & Stotzky G (1986): Selenium and immune responses (Review). Environ. Res. 42, 277-303.
28. Kiremidijan-Schumacher L, Roy M, Wishe HI, Cohen MW & Stotzky G (1994): Supplementation with selenium and humane immune cell functions. Effect on cytotoxic lymphocytes and natural killer cells. Biol. Trace. Elem. Res. 41, 115-127.
29. Lowry OH, Rosenburgh NJ, Farr AL & Randall RJ (1951): Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
30. Matsumoto T, Miike T, Nelson RP, Trudeau WL, Lockey RF & Yodoi J (1993): Elevated serum levels of IL-8 in patients with HIV infection. Clin. Exp. Immunol. 93(2), 149-151.
31. Matsuyama T, Kobayashi N & Yamamoto N (1991): Cytokines and HIV-infection: is AIDS a tumor necrosis factor disease? AIDS 5, 1405-1417.
32. Müller F (1992): Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection. Free. Rad. Biol. Med. 13, 651-657.
33. Munir P, Williams D, Tingle MD, Barry M, Khoo SH, O'Mahony C, Wilkins EGL, Breckenridge AM & Park BK (1996): Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency. AIDS 10, 501-507.
34. Olmsted L, Schrauzer GN, Flores-Arce M & Dowd J (1989): Selenium supplementation of symptomatic human immunodeficiency virus infected patients. Biol. Trace. Elem. Res. 20, 59-65.
35. Pace GW & Leaf CD (1995): The role of oxidative stress in HIV disease. Free. Rad. Biol. Med. 19(4), 523-221.
36. Petrie HT, Klassen LW & Kay HD (1989): Selenium and the immune response: 1. Modulation of alloreactive human lymphocyte functions in vitro. J. Leukocyte. Biol. 45, 207-214.
37. Revillard JP, Vincent C, Favier AE, Richard MJ, Zittoun M & Kazatchkine MD (1992): Lipid peroxidation in human immunodeficiency virus infection. J. Acquir. Immune. Defic. Syndr. Hum. Retrovir. 5(6), 63-68.
38. Roederer M, Ela SE, Staal FJT, Herzenberg LA & Herzenberg LA (1992): N-Acetylcysteine: a new approach to anti-HIV therapy. AIDS Res. Hum. Retrovir. 8(2), 209-217.
39. Roederer M, Staal FJT, Ela SW, Herzenberg LA & Herzenberg LA (1993): N-Acetylcysteine: potential for AIDS therapy. Pharmacology 46, 121-129.
40. Roy M, Kiremdjian-Schumacher L, Wishe HI, Cohnen MW & Stotzky G (1994): Supplementation with selenium and human immune cell functions. Effect on lymphocyte proliferation and interleukin 2 receptor expression. Biol. Trace. Elem. Res. 41, 103-114.
41. Sandstrom PA, Tebbey PW, van Cleave S & Buttke TM (1994): Lipid hydroperoxides induce apoptosis in T cells displaying a HIV-associated glutathione peroxidase deficiency. J. Biol. Chem. 269(2), 798-801.
42. Sappey C, Legrand-Poels S, Best-Belpomme M, Favier A, Rentier B & Piette J (1994): Stimulation of glutathione peroxidase activity decreases HIV Type 1 activation after oxidative stress. AIDS Res. Hum. Retrovir. ,10(10), 1451-1459.
43. Schreck R, Albermann K & Auerle P (1992): Nuclear factor KB: An oxidative stress-response transcription factor of eukaryotic cells (a review). Free. Rad. Res. Comms. 17(4), 221-237.
44. Staal FJT, Roederer M, Faju P, Anderson MT, Ela SW, Herzenberg LA & Herzenberg LA (1993): Antioxidants inhibit stimulation of HIV transcription. AIDS Res. Hum. Retrovir. 9(4), 299-306.
45. Stabel JR & Spears JW (1993): Nutrition and Immunology; Role of selenium in immune responsiveness and disease resistance. In: Klurfeld DM (ed). Human Nutrition - A Comprehensive Treatise, Vol. 8 Plenum Press: New York pp 333-356.
46. Tietze F (1969): Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 27, 502-522.
47. Welz B, Melcher M & Schlemmer G (1983): Bestimmung von Selen im menschlichen Blutserum. Anal. Chem. 316, 271-276.
48. Wendel A (1981): Glutathione peroxidase. Methods Enzymol 77, 325-333.
49. Westendrop MO, Shatrov VA, Schulze-Osthoff K, Frank R, Kraft M, Los M, Krammer PH, Drge W & Lehmann V (1995): HIV-1 Tat potentiates TNF-induced NFκB activation and cytotoxicity by altering the cellular redox state. EMBO J 14(3), 546-554.